Coordination - management - training - public relations

KFO第一阶段的经验表明，临床研究单位在很大程度上取决于来自基础和临床研究不同学科的参与研究小组之间的合作和互动。如果合作得到良好协调，就可以分享和利用共同资源，这在很大程度上构成了这种联合体的附加值。因此，TP 9的主要目标之一将是协调计划的研究项目，未来发展KFO第一阶段形成的通信平台，并加强数据和结果的交流，以产生新的假设并将其转化为实验研究。特别是，我们将努力促进转化方法，使血小板生物学更接近临床应用。TP 9还为青年研究人员组织培训，教学和交流计划，并为KFO组织会议和会议，我们还将邀请外部演讲者。此外，TP 9整合并致力于进一步扩展患者数据库及其与现有电子病历的连接，组织和提供不同TP的中央服务（动物模型）以及与KFO有关的公共关系（主页，虚拟管理）。 我们设法聘请了Klaus Ley教授（拉霍亚，炎症生物学，自身免疫研究部门负责人兼教授），如果DFG批准，他可能被任命为KFO的Mercator教授。Ley教授是血小板功能及其与组织和血管炎症相关性领域的知名专家。Ley教授在KFO第二阶段的Mercator-Professorship的实施将最终推动该联盟，因为他是一位国际知名的研究人员，他的参与将明显提高我们KFO 274的国际知名度。

The previous experience during the first period of the KFO showed that a clinical research unit largely depends on cooperations and interactions in between the participating research groups coming from different disciplines of basic and clinical research. If the cooperations are well coordinated, common resources can be shared and used, which constitutes to a large extent the added value of such a consortium. One of the main goals of TP9, thus, will be coordination of the planned research projects, the future development of communication-platforms formed during the first period of the KFO and to intensify exchange of data and results to generate novel hypotheses and to transfer those into experimental studies. Particularly, we will try to promote translational approaches to bring platelet biology closer to clinical applications. TP 9 furthermore organizes training-, teaching and exchange programs for young researchers and meetings and conferences for the KFO, for which we will also invite speakers from outside. Moreover, TP 9 integrates and works on further extension of the patients database and its crosslinking with the existing electronic patient record, the organisation of and supply of the different TPs with central services (animal models) and the public relations concerning the KFO (homepage, virtual administration). We managed to aquire Prof. Klaus Ley (Division Head und Professor; Autoimmune Research; Inflammation Biology, La Jolla) for a potential appointment as Mercator-Professor integrated in the KFO, if granted by the DFG. Prof. Ley is a renowned expert in the area of platelet function and their relevance to tissue- and vascular inflammation. The implementation of the Mercator-Professorship for Prof. Ley in the 2nd period of the KFO will eventually advance the consortium as he is an internationally respected researcher and his participation will clearly increase the international visibility of our KFO 274.